An antibiotic selection marker for schistosome transgenesis
Drug selection is widely used in transgene studies of microbial pathogens, mammalian cell and plant cell lines. Drug selection of transgenic schistosomes would be desirable to provide a means to enrich for populations of transgenic worms. We adapted murine leukaemia retrovirus vectors - widely used...
Saved in:
Main Authors: | , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/14364 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
id |
th-mahidol.14364 |
---|---|
record_format |
dspace |
spelling |
th-mahidol.143642018-06-11T12:19:58Z An antibiotic selection marker for schistosome transgenesis Gabriel Rinaldi Sutas Suttiprapa José F. Tort Anne E. Folley Danielle E. Skinner Paul J. Brindley George Washington University Universidad de la Republica Facultad de Medicina Mahidol University Immunology and Microbiology Medicine Drug selection is widely used in transgene studies of microbial pathogens, mammalian cell and plant cell lines. Drug selection of transgenic schistosomes would be desirable to provide a means to enrich for populations of transgenic worms. We adapted murine leukaemia retrovirus vectors - widely used in human gene therapy research - to transduce schistosomes, leading to integration of transgenes into the genome of the blood fluke. A dose-response kill curve and lethal G418 (geneticin) concentrations were established: 125-1,000 μg/ml G418 were progressively more toxic for schistosomules of Schistosoma mansoni with toxicity increasing with antibiotic concentration and with duration of exposure. By day 6 of exposure to ≥500 μg/ml, significantly fewer worms survived compared with non-exposed controls and by day 8, significantly fewer worms survived than controls at ≥250 μg/ml G418. When schistosomules were transduced with murine leukaemia retrovirus encoding the neomycin resistance (neoR) transgene and cultured in media containing G418, the neoR transgene rescued transgenic schistosomules from the antibiotic; by day 4 in 1,000 μg/ml and by day 8 in 500 μg/ml G418, significantly more transgenic worms survived the toxic effects of the antibiotic. More copies of neoR were detected per nanogram of genomic DNA from populations of transgenic schistosomes cultured in G418 than from transgenic schistosomes cultured without G418. This trend was G418 dose-dependent, demonstrating enrichment of transgenic worms from among the schistosomules exposed to virions. Furthermore, higher expression of neoR was detected in transgenic schistosomes cultured in the presence of G418 than in transgenic worms cultured without antibiotic. The availability of antibiotic selection can be expected to enhance progress with functional genomics research on the helminth parasites responsible for major neglected tropical diseases. © 2011 Australian Society for Parasitology Inc. 2018-06-11T04:55:12Z 2018-06-11T04:55:12Z 2012-01-01 Article International Journal for Parasitology. Vol.42, No.1 (2012), 123-130 10.1016/j.ijpara.2011.11.005 18790135 00207519 2-s2.0-84855200901 https://repository.li.mahidol.ac.th/handle/123456789/14364 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84855200901&origin=inward |
institution |
Mahidol University |
building |
Mahidol University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Mahidol University Library |
collection |
Mahidol University Institutional Repository |
topic |
Immunology and Microbiology Medicine |
spellingShingle |
Immunology and Microbiology Medicine Gabriel Rinaldi Sutas Suttiprapa José F. Tort Anne E. Folley Danielle E. Skinner Paul J. Brindley An antibiotic selection marker for schistosome transgenesis |
description |
Drug selection is widely used in transgene studies of microbial pathogens, mammalian cell and plant cell lines. Drug selection of transgenic schistosomes would be desirable to provide a means to enrich for populations of transgenic worms. We adapted murine leukaemia retrovirus vectors - widely used in human gene therapy research - to transduce schistosomes, leading to integration of transgenes into the genome of the blood fluke. A dose-response kill curve and lethal G418 (geneticin) concentrations were established: 125-1,000 μg/ml G418 were progressively more toxic for schistosomules of Schistosoma mansoni with toxicity increasing with antibiotic concentration and with duration of exposure. By day 6 of exposure to ≥500 μg/ml, significantly fewer worms survived compared with non-exposed controls and by day 8, significantly fewer worms survived than controls at ≥250 μg/ml G418. When schistosomules were transduced with murine leukaemia retrovirus encoding the neomycin resistance (neoR) transgene and cultured in media containing G418, the neoR transgene rescued transgenic schistosomules from the antibiotic; by day 4 in 1,000 μg/ml and by day 8 in 500 μg/ml G418, significantly more transgenic worms survived the toxic effects of the antibiotic. More copies of neoR were detected per nanogram of genomic DNA from populations of transgenic schistosomes cultured in G418 than from transgenic schistosomes cultured without G418. This trend was G418 dose-dependent, demonstrating enrichment of transgenic worms from among the schistosomules exposed to virions. Furthermore, higher expression of neoR was detected in transgenic schistosomes cultured in the presence of G418 than in transgenic worms cultured without antibiotic. The availability of antibiotic selection can be expected to enhance progress with functional genomics research on the helminth parasites responsible for major neglected tropical diseases. © 2011 Australian Society for Parasitology Inc. |
author2 |
George Washington University |
author_facet |
George Washington University Gabriel Rinaldi Sutas Suttiprapa José F. Tort Anne E. Folley Danielle E. Skinner Paul J. Brindley |
format |
Article |
author |
Gabriel Rinaldi Sutas Suttiprapa José F. Tort Anne E. Folley Danielle E. Skinner Paul J. Brindley |
author_sort |
Gabriel Rinaldi |
title |
An antibiotic selection marker for schistosome transgenesis |
title_short |
An antibiotic selection marker for schistosome transgenesis |
title_full |
An antibiotic selection marker for schistosome transgenesis |
title_fullStr |
An antibiotic selection marker for schistosome transgenesis |
title_full_unstemmed |
An antibiotic selection marker for schistosome transgenesis |
title_sort |
antibiotic selection marker for schistosome transgenesis |
publishDate |
2018 |
url |
https://repository.li.mahidol.ac.th/handle/123456789/14364 |
_version_ |
1763489771539136512 |